Panjon Limited (BOM:526345)
India · Delayed Price · Currency is INR 24.82
+0.44 (1.80%)
At close: Mar 5, 2026
Panjon Revenue
Panjon had revenue of 141.39M INR in the quarter ending December 31, 2025, with 26.74% growth. This brings the company's revenue in the last twelve months to 493.34M, up 125.97% year-over-year. In the fiscal year ending March 31, 2025, Panjon had annual revenue of 304.58M with 142.65% growth.
Revenue (ttm)
493.34M
Revenue Growth
+125.97%
P/S Ratio
0.86
Revenue / Employee
12.33M
Employees
40
Market Cap
426.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 304.58M | 179.06M | 142.65% |
| Mar 31, 2024 | 125.52M | 64.61M | 106.07% |
| Mar 31, 2023 | 60.91M | -23.41M | -27.76% |
| Mar 31, 2022 | 84.32M | -61.07M | -42.00% |
| Mar 31, 2021 | 145.39M | -55.58M | -27.66% |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Welcure Drugs and Pharmaceuticals | 3.66B |
| Mangalam Drugs & Organics | 2.38B |
| Walpar Nutritions | 757.46M |
| JFL Life Sciences | 744.78M |
| Sandu Pharmaceuticals | 671.50M |
| Shelter Pharma | 598.96M |
| Rajnish Wellness | 455.79M |